Mestastop Solutions

Mestastop Solutions

Private
Bangalore, KarnatakaHealthcare & Life Scienceshttps://www.mestastop.com

Last Round

Grant

Nov 27, 2024

Total Funding Raised

$993,000

Company Overview

Mestastop Solutions is a biotechnology company founded in 2018 that specializes in cancer metastasis. The company is developing a suite of proprietary platforms (METAssay, METSCAN, and METVivo) that utilize patient tumor samples, wet-lab biology, predictive analytics, and machine learning to understand the process of metastasis. Its primary goal is to create intellectual property for novel drug discovery, drug repurposing, and predictive diagnostics to prevent or delay the spread of cancer. The company operates on a B2B model, intending to out-license, collaborate, or partner with pharmaceutical and biotech companies. Mestastop has received multiple rounds of funding, including a Pre-Series A in 2023, and has active research collaborations and plans for clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cancer metastasisdrug discovery platformmetastasis modelinganti-metastatic therapeuticsphenotypic assayspredictive diagnosticstranslational platformpatient-derived modelsdrug repurposingmetastasis animal modelCRO serviceshigh-throughput screeningpreclinical modelscontract research organizationCROPDX modelsfee-for-servicecompanion diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mestastop Solutions Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mestastop Solutions Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 27, 2024
Pre SeedOct 19, 2023
SeedOct 19, 2021
AngelSep 24, 2020

Mestastop Solutions Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2025

    Named Best Metastasis R&D Specialist for 2025 by GHP.

  • Apr 21, 2025

    Received the GHP Innovation Excellence Award for the second year in a row.

Mestastop Solutions Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mestastop Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mestastop Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore, Karnataka
Employee Range23
Year Founded2018
Last FundingNov 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.